Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet A Schlechte

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Psychiatry|January 17, 2012
Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogeneticsChadi A Calarge, Vicki L Ellingrod, Bridget Zimmerman, et al.
Psychiatric Genetics|October 31, 2009
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Bridget Zimmerman, et al.
Pituitary|September 3, 2010
Demographic differences in incidence for pituitary adenomaBradley D McDowell, Robert B Wallace, Ryan M Carnahan, et al.
The Journal of Clinical Psychiatry|November 19, 2015
Fat distribution and major depressive disorder in late adolescenceWilliam H Coryell, Brandon D Butcher, Trudy L Burns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 12, 2014
Major depressive disorder and bone mass in adolescents and young adultsChadi A Calarge, Brandon D Butcher, Trudy L Burns, et al.
Pharmacogenetics and Genomics|April 3, 2009
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Laura Acion, et al.
Therapeutic Advances in Psychopharmacology|October 30, 2013
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescentsChadi A Calarge, Stephanie D Ivins, Katherine J Motyl, et al.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2011
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guidelineShlomo Melmed, Felipe F Casanueva, Andrew R Hoffman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2017
The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging AdultsChadi A Calarge, James A Mills, Kathleen F Janz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 11, 2016
The Relationship Between Greater Prepubertal Adiposity, Subsequent Age of Maturation, and Bone Strength During AdolescenceNatalie A Glass, James C Torner, Elena M Letuchy, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Psychiatry|January 17, 2012
Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogeneticsChadi A Calarge, Vicki L Ellingrod, Bridget Zimmerman, et al.
Psychiatric Genetics|October 31, 2009
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Bridget Zimmerman, et al.
Pituitary|September 3, 2010
Demographic differences in incidence for pituitary adenomaBradley D McDowell, Robert B Wallace, Ryan M Carnahan, et al.
The Journal of Clinical Psychiatry|November 19, 2015
Fat distribution and major depressive disorder in late adolescenceWilliam H Coryell, Brandon D Butcher, Trudy L Burns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 12, 2014
Major depressive disorder and bone mass in adolescents and young adultsChadi A Calarge, Brandon D Butcher, Trudy L Burns, et al.
Pharmacogenetics and Genomics|April 3, 2009
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescentsChadi A Calarge, Vicki L Ellingrod, Laura Acion, et al.
Therapeutic Advances in Psychopharmacology|October 30, 2013
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescentsChadi A Calarge, Stephanie D Ivins, Katherine J Motyl, et al.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2011
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guidelineShlomo Melmed, Felipe F Casanueva, Andrew R Hoffman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2017
The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging AdultsChadi A Calarge, James A Mills, Kathleen F Janz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 11, 2016
The Relationship Between Greater Prepubertal Adiposity, Subsequent Age of Maturation, and Bone Strength During AdolescenceNatalie A Glass, James C Torner, Elena M Letuchy, et al.
Pageof 3